PTX3 values were significantly high in patients with obesity (body mass index (BMI) ≥ 30), cardiovascular diseases, and continuous systemic cortisone treatment (daily dose over 10 mg oral prednisolone) compared to those without these risk factors [25]. This evidence concerns the gene PTX3 and obesity disorder.